Resistance to antimalarial drugs is a significant challenge in the fight against malaria. Plasmodium falciparum has developed resistance to many drugs, including chloroquine and sulfadoxine-pyrimethamine. Drug resistance leads to higher rates of treatment failure, which can result in increased morbidity and mortality. Therefore, continuous research and development of new antimalarial agents are crucial.
